rs750625

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -15 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_ModerateBP6_StrongBP7

The NM_000037.4(ANK1):c.5265G>A (p.Val1755Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.234 (AC=377,206) in the gnomAD database across 1,614,112 control chromosomes, including 45,182 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.272. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★).

Frequency

Genomes: 𝑓 0.23 ( 4040 hom., cov: 33)
Exomes 𝑓: 0.23 ( 41142 hom. )

Consequence

ANK1
NM_000037.4 synonymous

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 1.27

Publications

28 publications found
Variant links:
Genes affected
ANK1 (HGNC:492): (ankyrin 1) Ankyrins are a family of proteins that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 1, the prototype of this family, was first discovered in the erythrocytes, but since has also been found in brain and muscles. Mutations in erythrocytic ankyrin 1 have been associated in approximately half of all patients with hereditary spherocytosis. Complex patterns of alternative splicing in the regulatory domain, giving rise to different isoforms of ankyrin 1 have been described. Truncated muscle-specific isoforms of ankyrin 1 resulting from usage of an alternate promoter have also been identified. [provided by RefSeq, Dec 2008]
ANK1 Gene-Disease associations (from GenCC):
  • hereditary spherocytosis
    Inheritance: AD, AR Classification: DEFINITIVE, SUPPORTIVE, LIMITED Submitted by: Orphanet, ClinGen
  • hereditary spherocytosis type 1
    Inheritance: SD, AR, AD Classification: STRONG, LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000037.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript

Our verdict: Benign. The variant received -15 points.

BP4
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Moderate).
BP6
ClinVar 2-star benign — strong (BP6); ClinVar submissions overwhelmingly benign (≥10 total, ≥80% B/LB, <10% P/LP) — strong (BP6, count-based); ClinVar germline classification: Benign/Likely Benign, 2 star(s). ClinVar submissions strongly and reliably favor benignity (11/11 total B/LB).
BP7
Synonymous variant at non-conserved position with no predicted splicing impact (BP7); Synonymous at non-conserved position, no splicing concern — benign (BP7).
BA1
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.2717 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000037.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK1
NM_000037.4
MANE Select
c.5265G>Ap.Val1755Val
synonymous
Exon 39 of 43NP_000028.3
ANK1
NM_001142446.2
c.5388G>Ap.Val1796Val
synonymous
Exon 40 of 43NP_001135918.1P16157-21
ANK1
NM_020476.3
c.5265G>Ap.Val1755Val
synonymous
Exon 39 of 42NP_065209.2P16157-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK1
ENST00000289734.13
TSL:1 MANE Select
c.5265G>Ap.Val1755Val
synonymous
Exon 39 of 43ENSP00000289734.8P16157-3
ANK1
ENST00000265709.14
TSL:1
c.5388G>Ap.Val1796Val
synonymous
Exon 40 of 43ENSP00000265709.8P16157-21
ANK1
ENST00000347528.8
TSL:1
c.5265G>Ap.Val1755Val
synonymous
Exon 39 of 42ENSP00000339620.4P16157-1

Frequencies

GnomAD3 genomes
AF:
0.227
AC:
34461
AN:
152128
Hom.:
4030
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.199
Gnomad AMI
AF:
0.376
Gnomad AMR
AF:
0.258
Gnomad ASJ
AF:
0.292
Gnomad EAS
AF:
0.128
Gnomad SAS
AF:
0.198
Gnomad FIN
AF:
0.201
Gnomad MID
AF:
0.294
Gnomad NFE
AF:
0.243
Gnomad OTH
AF:
0.249
GnomAD2 exomes
AF:
0.217
AC:
54591
AN:
251474
AF XY:
0.219
show subpopulations
Gnomad AFR exome
AF:
0.199
Gnomad AMR exome
AF:
0.195
Gnomad ASJ exome
AF:
0.290
Gnomad EAS exome
AF:
0.124
Gnomad FIN exome
AF:
0.210
Gnomad NFE exome
AF:
0.241
Gnomad OTH exome
AF:
0.226
GnomAD4 exome
AF:
0.234
AC:
342714
AN:
1461866
Hom.:
41142
Cov.:
37
AF XY:
0.235
AC XY:
170673
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.202
AC:
6748
AN:
33480
American (AMR)
AF:
0.200
AC:
8932
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.288
AC:
7536
AN:
26136
East Asian (EAS)
AF:
0.131
AC:
5190
AN:
39700
South Asian (SAS)
AF:
0.200
AC:
17267
AN:
86258
European-Finnish (FIN)
AF:
0.206
AC:
11000
AN:
53416
Middle Eastern (MID)
AF:
0.283
AC:
1633
AN:
5768
European-Non Finnish (NFE)
AF:
0.243
AC:
270426
AN:
1111988
Other (OTH)
AF:
0.232
AC:
13982
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
18067
36134
54201
72268
90335
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9092
18184
27276
36368
45460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.227
AC:
34492
AN:
152246
Hom.:
4040
Cov.:
33
AF XY:
0.227
AC XY:
16879
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.199
AC:
8284
AN:
41546
American (AMR)
AF:
0.258
AC:
3951
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.292
AC:
1012
AN:
3468
East Asian (EAS)
AF:
0.127
AC:
660
AN:
5186
South Asian (SAS)
AF:
0.199
AC:
960
AN:
4818
European-Finnish (FIN)
AF:
0.201
AC:
2133
AN:
10606
Middle Eastern (MID)
AF:
0.293
AC:
86
AN:
294
European-Non Finnish (NFE)
AF:
0.243
AC:
16543
AN:
68004
Other (OTH)
AF:
0.246
AC:
520
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1402
2804
4205
5607
7009
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
354
708
1062
1416
1770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
TOPMed (Bravo)
AF:
0.231
AC:
61162
AN:
264690
Hom.:
7337
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF:
0.236
AC:
110733
AN:
468812
Hom.:
13817

Local populations

ABraOM SABE-WGS-1171
AF:
0.248
AC:
580
AN:
2342
Hom.:
73
ChinaMAP Phase 1
AF:
0.120
Denmark Genome
AF:
0.233
AC:
70
AN:
300
ESP6500 (Exome Variant Server)
AF:
0.231
AC:
3007
AN:
13006
show subpopulations
European American
AF:
0.245
AC:
2107
AN:
8600
African American
AF:
0.204
AC:
900
AN:
4406
GenomeAsia100K
AF:
0.141
AC:
490
AN:
3478
show subpopulations
Oceania
AF:
0.0270
AC:
4
AN:
148
Hom.:
0
North-East Asia
AF:
0.0997
AC:
70
AN:
702
Hom.:
3
South-East Asia
AF:
0.132
AC:
91
AN:
692
Hom.:
7
South Asia
AF:
0.148
AC:
215
AN:
1448
Hom.:
12
Africa
AF:
0.240
AC:
50
AN:
208
Hom.:
6
America
AF:
0.135
AC:
7
AN:
52
Hom.:
0
West Eurasia
AF:
0.232
AC:
53
AN:
228
Hom.:
5
Korea4K (4,157 Koreans)
AF:
0.115
AC:
830
AN:
7234
Qatari Genome
AF:
0.237
AC:
477
AN:
2010
ToMMo 61KJPN (+60KJPN MNV)
AF:
0.139
AC:
17021
AN:
122770
Hom.:
1219
Turkish Variome
AF:
0.297
AC:
1999
AN:
6720
Hom.:
325
UK10K
AF:
0.247
AC:
1867
AN:
7562
show subpopulations
TwinsUK
AF:
0.245
AC:
874
AN:
3574
ALSPAC
AF:
0.250
AC:
964
AN:
3854
WBBC (Westlake BioBank for Chinese) pilot
AF:
0.133
AC:
1195
AN:
8960
Hom.:
80

Case/control cohorts

Cohort
Cases
Controls
ASC
(Autism)
2404 / 11002AF: 0.218506
3682 / 17524AF: 0.210112
BipEx
(Bipolar disorder (including schizoaffective))
6536 / 28420AF: 0.229979
6738 / 28844AF: 0.233601
Epi25
(Epilepsy)
9893 / 41958AF: 0.235783
15999 / 66888AF: 0.239191
SCHEMA
(Schizophrenia)
33954 / 137270AF: 0.247352
59660 / 225620AF: 0.264427

Allele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
Hereditary spherocytosis type 1 (5)
-
-
3
not provided (3)
-
-
2
not specified (2)
-
-
1
Spherocytosis (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
2.1
DANN
Benign
0.60
PhyloP100
1.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
AlphaGenome AVI
Benign
9.0
GPN-Star LLR
-1.5
GPN-Star score
1.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2
Pangolin (max)
Benign
0.010

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs750625;
hg19: chr8-41525914;
COSMIC: COSV55881841;
COSMIC: COSV55881841;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.